Summit Therapeutics Correlations

SMMT Stock  USD 18.94  0.26  1.35%   
The current 90-days correlation between Summit Therapeutics PLC and Nkarta Inc is 0.36 (i.e., Weak diversification). The correlation of Summit Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Summit Therapeutics Correlation With Market

Modest diversification

The correlation between Summit Therapeutics PLC and DJI is 0.24 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Summit Therapeutics PLC and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Summit Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Moving together with Summit Stock

  0.62BCYC Bicycle TherapeuticsPairCorr

Moving against Summit Stock

  0.32PIRS Pieris PharmaceuticalsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
OCEAZVSA
ZVSACGEM
CGEMNKTX
ZVSANKTX
OCEACGEM
OCEANKTX
  
High negative correlations   
ICVXNKTX
ICVXELEV
KZRNKTX
ICVXCGEM
ICVXZVSA
KZRCGEM

Risk-Adjusted Indicators

There is a big difference between Summit Stock performing well and Summit Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Summit Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Summit Therapeutics Corporate Management

Elaine JDHead CounselProfile
Fong ClowChief OfficerProfile
Betty ChangOncology ResearchProfile
Bhaskar AnandChief FinanceProfile
Will BlackHead TechnologyProfile